Immediate Impact

2 from Science/Nature 64 standout
Sub-graph 1 of 23

Citing Papers

Rheumatoid arthritis: pathogenesis and therapeutic advances
2024 Standout
Persistent physical symptoms: definition, genesis, and management
2024 Standout
8 intermediate papers

Works of Christopher M. Mela being referenced

Clinical efficacy and safety maintained up to 5 years in patients with rheumatoid arthritis treated with tocilizumab in a randomised trial.
2016
Effect of rituximab on physical function and quality of life in patients with rheumatoid arthritis previously untreated with methotrexate
2010
and 2 more

Author Peers

Author Last Decade Papers Cites
Christopher M. Mela 126 227 68 69 16 366
Afroditi Boulougoura 92 156 39 31 19 340
Astrid Rascu 97 146 47 51 13 348
Nurit Vardinon 157 118 76 30 14 384
D E Tee 27 148 46 40 16 325
A Hiraoka 27 120 64 49 19 323
Lorella Lanza 41 238 20 34 22 385
H. Deicher 65 111 18 86 26 327
Vincenzo Carbonelli 133 163 16 24 15 343
Josep Maria Llobet 116 78 13 82 18 321
Cristina Feruglio 31 245 20 66 21 404

All Works

Loading papers...

Rankless by CCL
2026